Live Breaking News & Updates on Cura Foundation Robert Rosenson

Stay updated with breaking news from Cura foundation robert rosenson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Zodasiran Reduces Triglycerides, ANGPTL3 in Mixed Hyperlipidemia in ARCHES-2 Trial

A phase 2 trial suggests zodasiran significantly reduces triglycerides in patients with mixed hyperlipidemia, showing dose-dependent improvements in lipid profiles. ....

Robert-rosenson , Cura-foundation-robert-rosenson , Metabolism-for-the-mount-sinai-health-system , European-atherosclerosis-society , Icahn-school-of-medicine-at-mount-sinai , Pearson , Cura-foundation , Icahn-school , Mount-sinai , Mount-sinai-health-system , Confidence-interval ,